On 2025-05-08, Immix Biopharma, Inc. (IMMX) announced earnings per share of $-0.15 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.23.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.21 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.23 | $-0.15 |
| 2025-03-24 | 2024-12-31 | $-0.25 | $-0.16 |
| 2024-11-12 | 2024-09-30 | $-0.16 | $-0.24 |
| 2024-08-12 | 2024-06-30 | $-0.21 | $-0.15 |
| 2024-05-09 | 2024-03-31 | $-0.23 | $-0.22 |
| 2024-03-29 | 2023-12-31 | -- | $-0.24 |
| 2023-11-09 | 2023-09-30 | $-0.23 | $-0.23 |
| 2023-08-11 | 2023-06-30 | $-0.17 | $-0.24 |
| 2023-05-12 | 2023-03-31 | $-0.14 | $-0.18 |
| 2023-03-27 | 2022-12-31 | -- | $-0.27 |
| 2022-11-09 | 2022-09-30 | -- | $-0.11 |
| 2022-08-12 | 2022-06-30 | -- | $-0.11 |
| 2022-05-13 | 2022-03-31 | -- | $-0.10 |